immunoglobulin A vasculitis
immunoglobulin A vasculitis
Explore linked clinical trials. Standard reference: MONDO:001916712 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized Multicenter Study for Isolated Skin Vasculitis | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, cutaneous polyarteritis nodosa, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Phase 2 | 2026-08-20 | NCT02939573 | |
| Study of Ravulizumab in Pediatric Participants With Primary IgAN | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, blood coagulation disease, cardiovascular disorder, glomerulonephritis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, kidney disorder, nephritis, proteinuria, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, urinary system disorder, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Phase 3 | 2026-07-30 | NCT07024563 | |
| I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-06-24 | NCT07664228 | |
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases | Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, blood coagulation disease, cardiovascular disorder, connective tissue disorder, focal segmental glomerulosclerosis, glomerulonephritis, hematologic disorder, hemorrhagic disease, hereditary nephritis, immune system disorder, immunoglobulin A vasculitis, kidney disorder, macular corneal dystrophy, minimal change disease, nephritis, nephrosis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, urinary system disorder, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Phase 2 | 2026-05-12 | NCT05003986 | |
| Vasculitis Pregnancy Registry | Aortic Arch Syndromes, Behcet disease, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Takayasu arteritis, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, eosinophilic granulomatosis with polyangiitis, eye disorder, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, mouth disorder, necrotizing vasculitis, nervous system disorder, panuveitis, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, uveal disorder, uveitis, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-23 | NCT02593565 | |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | Cerebral Small Vessel Diseases, Cryoglobulinemic vasculitis, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, arteritis, autoimmune disease, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, drug-induced vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT03004326 | |
| VCRC Tissue Repository | Aortic Arch Syndromes, Cerebral Small Vessel Diseases, Granuloma, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Takayasu arteritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, aortic disorder, aortitis, arteritis, autoimmune disease, autoimmune disorder of the nervous system, blood coagulation disease, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system vasculitis, cerebrovascular disorder, cutaneous vasculitis, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, interstitial lung disease, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, polyarteritis nodosa, purpura, respiratory system disorder, skin disorder, skin vascular disease, temporal arteritis, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not stated | 2026-01-22 | NCT02967068 | |
| Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Not yet recruiting | Not stated | 2026-01-21 | NCT07354503 | |
| Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, blood coagulation disease, cardiovascular disorder, chronic renal failure syndrome, glomerulonephritis, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, kidney disorder, kidney failure, nephritis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, urinary system disorder, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Phase 4 | 2025-07-14 | NCT06676384 | |
| Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not applicable | 2025-02-19 | NCT03647852 | |
| Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not applicable | 2023-07-19 | NCT05951517 | |
| Leflunomide for Henoch-Schonlein Purpura | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, blood coagulation disease, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoglobulin A vasculitis, purpura, skin disorder, skin vascular disease, type III hypersensitivity disease, vascular disorder, vascular hemostatic disease, vasculitis | Recruiting | Not applicable | 2023-07-10 | NCT05937880 |